Publicaciones en colaboración con investigadores/as de Universitat Pompeu Fabra (8)

2021

  1. Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in Aurora, the breast international group (Big) molecular screening initiative

    Cancer Discovery, Vol. 11, Núm. 11, pp. 2796-2811

2019

  1. Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: An estimation of life years and disease-free life years gained since its approval

    Oncotarget, Vol. 10, Núm. 42, pp. 4321-4332

  2. Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer

    ecancermedicalscience, Vol. 13

2018

  1. Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    Clinical and Translational Oncology, Vol. 20, Núm. 7, pp. 815-826

  2. Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia

  3. Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology (Clinical and Translational Oncology, (2018), 20, 7, (815-826), 10.1007/s12094-017-1800-5)

    Clinical and Translational Oncology

2017

  1. Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics

    PLoS ONE, Vol. 12, Núm. 6

2014

  1. Trastuzumab in small tumours and in elderly women

    Cancer Treatment Reviews, Vol. 40, Núm. 1, pp. 41-47